David Shapiro, Chief Medical Officer at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 9,834 shares at $111.43 ($1.1M) on 2018-09-05, disclosed to the SEC on 2018-09-07.
Seasonal sale ($1.1M) by Chief Medical Officer — this insider has traded ICPT in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $111.43 | 4,917 | $548K | 50.0% |
| 2 | $111.43 | 4,917 | $548K | 50.0% |
| Total | $111.43 avg | 9,834 | $1.1M | 100% |
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |